Article Figures & Data
Figures
- Figure 1
- Symptoms prevelence at admission.
- Figure 2
- The prevelence of medical comorbidities presented among patients.
Tables
Variables n (%) Nationality Saudi 302 (43.8) Non-Saudi 387 (56.2) Gender Male 464 (67.3) Female 225 (32.7) Age, mean±SD 53.7±15.12 <30 40 (5.8) 31-60 422 (61.2) 61-90 224 (32.5) >90 3 (0.4) BMI, mean±SD 29.89±6.63 Underweight 15 (2.2) Normal weight 100 (14.5) Overweight 251 (36.4) Obese 323 (46.9) Initial location of admission Isolated ward 577 (83.7) ICU 101 (14.7) HDU 11 (1.6) Duration of hospitalization (days) 14.82±19.33 Duration of presenting symptoms at the time of admission (days) 6.09±3.52 Values are presented as numbers and precentages (%) or mean ± standard deviation (SD). BMI: body mass index, ICU: intensive care unit, HDU: high dependency unit
- Table 2
- Baseline laboratory test results in the total sample and between those received and not received statin.
Parameters Total Receiving statin P-values No Yes WBC (x10^9/L) 7.94±4.35 7.91±4.44 8.07±4.03 0.683 Hgb (g/L) 38.35±89.53 40.30±98.91 31.66±43.79 0.312 Absolute neutrophils (x10^9/L) 7.12±15.71 7.35±17.7 6.33±3.81 0.50 Absolute neutrophils (Low) (x10^9/L) 5.00±7.63 5.28±8.9 4.25±2.05 0.415 PLT (x10^9/L) 228.01±88.46 224.49±83.14 240.16±104.21 0.054 Absolute lymphocytes (x10^9/L) 1.46±6.0 1.49±6.74 1.35±1.83 0.804 ESR (mm/h) 66.90±33.86 64.34±33.49 75.48±33.78 0.001* INR 1.22±1.4 1.23±1.58 1.20±0.46 0.819 D-dimer (ug/ml) 2.06±3.85 2.10±4.2 1.92±2.31 0.653 Fibrinogen level (g/L) 8.57±28.08 9.11±32.13 6.83±1.61 0.594 Fibrinogen level (lowest) (g/L) 5.09±1.67 5.12±1.76 4.98±1.39 0.630 ALP (U/L) 102.73±40.11 94.00±42.25 126.00±26.00 0.259 AST (U/L) 77.87±258.9 77.69±282.82 78.55±132.13 0.980 ALT (U/L) 48.49±61.78 U/L 48.78±58.32 U/L 47.49±72.68 U/L 0.822 GGT (U/L) 129.93±132.01 129.97±131.15 129.82±140.81 0.998 Total bilirubin (umol/day) 15.17±20.66 14.21±18.45 18.65±27.01 0.023* Urea (mmol/L) 10.81±9.53 9.82±8.66 14.15±11.42 0.000* Creatinine (umol/day) 133.42±167.59 120.74±147.71 176.52±217.45 0.000* CK-MB (U/L) 51.88±70.85 47.65±62.84 66.01±91.62 0.008* CK (U/L) 531.62±1136.92 506.64±1053.67 612.85±1374.78 0.350 LDH (U/L) 522.77±1398.74 547.96±1589.1 439.68±282.48 0.553 Troponin-I (ng/mL) 0.57±3.69 0.19±1.52 1.88±7.09 0.000* CRP (mg/dL) 13.22±81.43 14.50±91.88 8.54±5.46 0.588 Ferritin (ng/mL) 699.57±639.56 733.84±668.89 580.99±511.9 0.066 Total cholesterol (mmol/L) 4.76±16.12 5.04±18.85 4.03±2.37 0.556 TGD (mmol/L) 2.60±9.96 2.17±4.47 3.72±17.55 0.149 HDL (mmol/L) 0.83±0.57 0.84±0.61 0.80±0.43 0.645 LDL (mmol/L) 303.09±2707.58 322.62±2672.17 252.74±2806.88 0.805 HbA1c (%) 7.34±2.52 7.12±2.48 8.13±2.48 0.000* Values are presented as mean ± standard deviation (SD).
WBC: white blood count, Hgb: Hemoglobin, PLT: platelet count, ESR: erythrocyte sedimentation rate, INR: International normalized ratio, ALP: alkaline phosphatase, AST: aspartate aminotransferase, ALT: alanine transaminase, GGT: gamma-glutamyl transferase, CK-MB: creatine kinase-myoglobin binding
↵* Significant at a p-value of <0.05.
- Table 3
- The relation between receiving statin and outcomes of patients with coronavirus disease-19.
Outcomes Received statin Risk associated with statin P-values No Yes RR (95% CI) Need for O2 No 118 (22.1) 25 (16.1) 1.47 (0.92:2.37) 0.107 Yes 416 (77.9) 130 (83.9) Admitted to ICU No 397 (74.3) 99 (63.9) 1.64 (1.12: 2.39) 0.011* Yes 137 (25.7) 56 (36.1) qSOFA score at admission to ICU No sepsis 478 (89.5) 133 (85.8) 1.41 (0.83: 2.39) 0.200 Sepsis 56 (10.5) 22 (14.2) Was patient intubated? No 441 (82.6) 113 (72.9) 1.76 (1.59: 2.68) 0.008* Yes 93 (17.4) 42 (27.1) Need inotropic support? No 481 (90.1) 134 (86.5) 1.42 (0.82: 2.44) 0.200 Yes 53 (9.9) 21 (13.5) Hospital complication None 435 (81.5) 99 (63.9) 2.48 (1.67: 3.68) 0.000* Yes 99 (18.5) 56 (36.1) Mortality No 502 (94.0) 129 (83.2) 3.16 (1.82: 5.49) 0.000* Yes 32 (6.0) 26 (16.8) Values are presented as numbers and precentages (%).
O2: oxygen, ICU: intensive care unit, qSOFA: quick sequential organ failure assessment, RR: relative risk, CI: confidence interval
↵* Significant at a p-value of <0.05.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.